Karnataka: Batch of popular beer brand recalled citing health concerns

BENGALURU :  After finding sediments in a popular brand of beer, the excise department has recalled the bottles supplied to depots and retail stores, citing health concerns.

An order to recall the bottles was issued on August 2 by the offices of Mysuru district commissioner of the
excise department and the deputy commissioner of excise of Bengaluru urban district.

The order stated that beer bottled on June 25 by United Breweries Limited at Nanjangud in Mysuru district contained some sediments. The order was issued based on a report from laboratories.

‘Inhouse chemists found no sediments in beer’

An excise official said, “The beer was bottled on June 25 and dispatched on July 15. The inhouse chemists found no sediments when it was bottled. Government clearance was also given. After 15 days, brewery officers found sediments in beer. So, we told depot officers to test the stock and they found sediments in beer.”

Excise officials said the batch numbers have been shared with all depots and retailers and they have been asked to withhold sales. There were 20,000 beer boxes in the distillery and 10,000 boxes in the depots. Beer bottled in Mysuru is supplied to five depots, including those in Bengaluru and Mysuru.

“We don’t have details on how many bottles have been sold, how many have reached retail outlets and how many are at the depots. We are collecting details,” the official said.

Stating that the beer containing sediments is not poisonous, he said, “They are not chemicals. During filtration, some sediments have not got filtered. The beer does not fulfill the criteria set by the Bureau of Indian Standards. If a person consumes it, he may suffer from a bad stomach for some days. So as a precautionary measure, we have recalled the bottles. We have also alerted the consumers.”

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?